Answers are grounded in this paper and cite their sources.
// Rashmi Kanagal-Shamanna 1 , Rajyalakshmi Luthra 1 , Cameron C. Yin 1 , Keyur P. Patel 1 , Koichi Takahashi 2 , Xinyan Lu 1 , John Lee 1 , Chong Zhao 1 , Francesco Stingo 2 , Zhuang Zuo 1 , Mark J. Routbort 1 , Rajesh R. Singh 1 , Patricia Fox 2 , Farhad Ravandi 3 , Guillermo Garcia-Manero 3 , L. Jeffrey Medeiros 1 , Carlos E. Bueso-Ramos 1 1 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 3 Department of Statistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Correspondence to: Rashmi Kanagal-Shamanna, e-mail: Rkanagal@mdanderson.org Carlos E. Bueso-Ramos, e-mail: cbuesora@mdanderson.org Keywords: myeloid neoplasms, isochromosome 17q, SETBP1, SRSF2, ASXL1 Received: December 17, 2015 Accepted: January 29, 2016 Published: February 12, 2016 ABSTRACT Isolated isochromosome 17q, i(17q), accounts for less than 1% of myeloid neoplasms that are commonly classified as myelodysplastic/myeloproliferative neoplasms, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPN). We have shown previously that these cases have distinctive clinicopathologic features, a poor prognosis and absence of TP53 mutations. However, their molecular mutation profile has not been studied. Here, we explored the mutation profile of 32 cases of myeloid neoplasm with isolated i(17q) that included AML, MDS/MPN, MDS and MPN. In addition to the common i(17q), these neoplasms had frequent mutations in SRSF2 (55%), SETBP1 (59%), ASXL1 (55%), and NRAS (31%); TET2 and TP53 mutations were rare. Eight of 28 patients (29%) showed concurrent mutations in ASXL1, SRSF2, SETBP1 and RAS . There was a significant association between mutations in SETBP1 and RAS ( p = 0.003). The mutation pattern was independent of the morphologic diagnosis. Sequential analysis of 5 cases showed evolution from a diploid karyotype to i(17q) and that SRSF2 and ASXL1 mutations precede the detection of i(17q) whereas SETBP1 mutations are associated with i(17q).
No takes yet. Share an insight, caveat, or question.
Kanagal‐Shamanna et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: